Filing Details
- Accession Number:
- 0001209191-15-005096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-20 16:32:43
- Reporting Period:
- 2015-01-16
- Filing Date:
- 2015-01-20
- Accepted Time:
- 2015-01-20 16:32:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612396 | D Matthew Dallas | C/O Aveo Pharmaceuticals, Inc. 650 E. Kendall Street Cambridge MA 02142 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-01-16 | 3,075 | $0.82 | 14,506 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2014, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.801 to $0.84, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Billionaire Hedge Funds
